Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-07-11)Premium Content

Eli Lilly And Co (LLY)

2014-07-23@13:26:54 ET
Eli Lilly (LLY) Breaks Through Resistance at $64.10 (PSM)

2014-07-23@11:21:36 ET
Eli Lilly (LLY) Showing Bullish Technicals (FBM)

2014-07-23@11:11:18 ET
China Insulin Delivery Devices Market 2006-2019 (MTO)

2014-07-23@11:11:08 ET
China Diabetes Management Devices Market Assessment and Forecasts, 2019 (MTO)

2014-07-23@10:18:05 ET
17.0% Return Seen to Date on SmarTrend Eli Lilly Call (LLY) (PSM)

2014-07-23@09:19:00 ET
Global Women's Health Market 2014-2018 (MTO)

2014-07-23@06:14:01 ET
Daiichi Sankyo and Eli Lilly and Company: Heart patients in England and Wales offered more choice of therapies as NICE extends recommendations for prasugrel (BIZ)

2014-07-23@05:59:48 ET
Pipeline Analysis and Sales Projections of the Top 25 Pharmaceutical Companies 2013-2023 (MTO)

2014-07-23@05:00:16 ET
Global Animal Antimicrobials and Antibiotics (Tetracyclines, Penicillins, Sulfonamides, Aminoglycosides) Market 2014-2018 (MTO)

2014-07-22@16:18:11 ET
Watch for Continued Gains in Shares of Eli Lilly (LLY) (F71)

2014-07-22@11:53:30 ET
Eli Lilly (LLY) Trading Near $62.42 Support Level (FBM)

2014-07-22@11:18:20 ET
Eli Lilly (LLY) Approaches New Upside Target of $64.30 (F79)

2014-07-22@09:21:42 ET
US Diabetes Management Devices Market Outlook and Trends to 2019 (MTO)

2014-07-22@07:02:01 ET
Research and Markets: 2014 Global Non-Hodgkin Lymphoma Therapeutics Market Report Featuring Bristol Myers Squibb, Celgen, Eli Lilly and Co, F. Hoffman La-Roche & GSK (BIZ)

2014-07-22@06:31:37 ET
2014 Global Non-Hodgkin Lymphoma Therapeutics Market Report Featuring Bristol Myers Squibb, Celgen, Eli Lilly and Co, F. Hoffman La-Roche & GSK (MTO)

2014-07-21@19:40:50 ET
CII releases National White Paper on tackling Non Communicable Diseases within PSEs (ABW)

2014-07-21@17:19:39 ET
Abdul Kalam release White Paper at 2nd National NCD Sumit (ABW)

2014-07-21@15:40:30 ET
Eli Lilly: 52-Week High Recently Eclipsed (LLY) (F71)

2014-07-21@09:30:00 ET
The Zacks Analyst Blog Highlights: Anthera Pharmaceuticals, Amgen, Eli Lilly, Actelion and InterMune (PRN)

2014-07-21@08:40:00 ET
Technical Pointers on Pharma Equities -- AbbVie, Johnson and Johnson, Merck, Bristol-Myers Squibb, and Eli Lilly (PRN)